Apparatus and method for measuring ocular tissue properties
By using an OCT system with multiple parallel beams at multiple locations simultaneously, the intensity and phase of the OCT signal are analyzed, solving the distortion problem caused by eye movement in in vivo testing of OCT technology. This enables rapid and accurate measurement of ocular tissue characteristics and image generation, avoiding the use of contrast agents.
Patent Information
- Application Number
- CN202480047465.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-08-29
- Filing Date
- 2024-08-15
- Publication Date
- 2026-02-13
AI Technical Summary
Existing OCT technology suffers from distortion of structural and growth values during in vivo human testing due to the patient's inherent eye movements, making it difficult to achieve rapid and accurate measurement of ocular tissue characteristics, and it also requires the injection of contrast agents.
Multiple parallel beams are used to simultaneously extract ocular tissue characteristics at multiple locations. The physiological information of ocular tissue is determined by analyzing the intensity and phase of the OCT signal. The diffusion coefficient of ocular tissue is measured by combining phase decorrelation technology, thus avoiding the need for contrast agent injection.
It enables rapid, stable, and distortion-free measurement of ocular tissue characteristics, providing high-resolution images and physiological information while avoiding invasive procedures for patients.
Smart Images

Figure CN121532113A_ABST
Abstract
Description
Cross Reference to Related Applications
[0001] This application claims the benefit of and priority to U.S. Provisional Patent Application No. 63 / 579,430, filed August 29, 2023, which is hereby assigned to the assignee of the present application, and which is hereby incorporated by reference in its entirety as if fully set forth below for all applicable purposes. BACKGROUND
[0002] It is known to use optical coherence tomography (OCT) scans to observe ocular tissue. SUMMARY
[0003] Some embodiments herein relate to an OCT scanning system for measuring a tissue property of a patient’s eye. The system includes an OCT scanner configured to implement a scan sequence on a cornea, a lens, an iris, a conjunctiva, a retina, and other ocular tissue via an optical signal. The scan sequence includes performing multiple scans on the eye to obtain OCT data. The OCT data is based on a reflected version of the optical signal; the OCT data represents phase data, intensity / amplitude data, or both phase data and amplitude data of the reflected version of the optical signal. In some embodiments, the system includes a computer including a processor.
[0004] In some embodiments, the processor is configured to provide control signals to the OCT scanner to implement the scan sequence and determine a rate of change of signal data associated with the multiple scans. The rate of change of signal data characterizes a change in the reflected version of the optical signal over time. In some embodiments, the processor determines a growth constant of the reflected version of the optical signal based on the rate of change of the phase data, and determines a diffusion coefficient associated with the cornea based on the growth constant. In some embodiments, the processor determines a quantitative parameter of the ocular tissue based on the diffusion coefficient associated with the tissue.
[0005] Some embodiments include a method of measuring ocular tissue properties, such as ocular thickness, topography, and curvature. The method includes using an optical coherence tomography (OCT) device and a computer coupled to the OCT device. The method can be performed by the computer in communication with the OCT device. Some embodiments include performing multiple scans on ocular tissue to obtain OCT data representing an OCT signal, including phase information and amplitude information, and measuring ocular tissue properties in real-time at multiple ocular locations.
[0006] In some embodiments, the method includes, at the OCT device, determining the rate of change of amplitude data or phase data, or a combination of amplitude and phase data, associated with the multiple scans, the rate of change characterizing the change of the reflected version of the optical signal over time. In some embodiments, the method includes determining a growth constant of the reflected version of the optical signal based on the rate of change of the data. In some embodiments, the method includes determining a diffusion coefficient associated with the ocular tissue based on the growth constant. In some embodiments, the method includes determining a quantitative parameter of the ocular tissue based on the diffusion coefficient associated with the ocular tissue.
[0007] Some embodiments include a computer program product comprising a non-transitory computer-readable medium. Some embodiments include a computer program product comprising a non-transitory computer-usable medium containing computer-readable program code. In some embodiments, the computer-readable program code is adapted to be executed by one or more processors to implement a method. In some embodiments, the method includes receiving OCT data representing an OCT signal from an OCT device, the OCT signal including phase information and amplitude information, the OCT data being generated by performing multiple scans on ocular tissue.
[0008] In some embodiments, the method includes determining the rate of change of amplitude or phase data associated with the multiple scans, the rate of change of phase or amplitude data characterizing a change in the reflected version of the optical signal over time. In some embodiments, the method includes determining a growth constant of the reflected version of the optical signal based on the rate of change of amplitude or phase data. In some embodiments, the method includes determining a diffusion coefficient associated with the ocular tissue based on the growth constant. In some embodiments, the method includes determining a quantitative parameter of the ocular tissue based on the diffusion coefficient associated with the ocular tissue. Attached Figure Description
[0009] To gain a detailed understanding of how the features described above are implemented, a more specific description of the disclosure can be provided with reference to embodiments (some of which are illustrated in the accompanying drawings). However, it should be noted that the drawings illustrate exemplary embodiments only and should not be construed as limiting the scope of the disclosure, and may allow for other equally effective embodiments.
[0010] Figure 1 An example configuration of an ophthalmic diagnostic system according to one or more embodiments is illustrated.
[0011] Figure 2 According to one or more embodiments Figure 1 A block diagram of the components of an ophthalmic diagnostic system.
[0012] Figure 3 Exemplary aspects of an ophthalmic diagnostic system according to one or more embodiments are illustrated.
[0013] Figures 4A-4D An exemplary process for measuring ocular tissue characteristics is illustrated according to one or more embodiments.
[0014] Figures 5A-5B An exemplary process for measuring ocular tissue characteristics is illustrated according to one or more embodiments.
[0015] For ease of understanding, the same reference numerals have been used where possible to refer to the same elements common to the figures. It is contemplated that elements and features of one embodiment can be advantageously combined in other embodiments without further description. Detailed Implementation
[0016] This disclosure will now be described in detail with reference to the accompanying drawings, which are provided as illustrative examples to enable those skilled in the art to practice this disclosure. In particular, the drawings and examples below are not intended to limit the scope of this disclosure to a single embodiment; other embodiments are possible through substitution of some or all of the elements described or illustrated. Furthermore, where certain elements of this disclosure are implemented partially or entirely using known components, only those portions of such known components necessary for understanding this disclosure will be described, and detailed descriptions of other portions of such known components will be omitted so as not to obscure this disclosure.
[0017] As used herein, unless the context clearly indicates otherwise, the singular forms “a,” “an,” and “the” include plural referents. As used herein, the expression “connected” means that these parts are joined together or operate together directly or indirectly (i.e., through one or more intermediate parts or components, as long as they are linked). As used herein, “directly connected” means that two elements are in direct contact with each other. As used herein, “fixedly connected” or “fixed” means that two components are connected to move as a whole while maintaining a constant orientation relative to each other. As used herein, “operationally connected” means that two elements are connected in a manner that works together. It should be understood that two elements “operationally connected” do not require a direct or permanent connection between them. As used herein, “substantially” means that any difference is negligible, such that any difference is within the operational tolerances known to those skilled in the art, and provides the desired performance and results described in the embodiments described herein. Descriptions of numerical ranges include endpoints.
[0018] As used herein, the term "integral" means that a component is produced as a single part or unit. That is, a component that includes parts produced separately and then joined together as units is not an "integral" component or body. As used herein, a statement that two or more parts or components are "engaged" with each other means that these parts exert force on each other directly or through one or more intermediate parts or components. As used herein, the term "quantity" means an integer of one or more (i.e., a plurality). Unless expressly stated herein, directional phrases used herein, such as, but not limited to, top, bottom, left, right, upper, lower, front, rear, and their derivatives, refer to the orientation of the elements shown in the accompanying drawings and do not limit the claims.
[0019] In the exemplary embodiments described herein, embodiments showing a single component should not be considered limiting; rather, unless expressly stated otherwise herein, this disclosure is intended to cover other embodiments including multiple identical components, and vice versa. Furthermore, the applicant does not intend to assign any terminology in the specification or claims an uncommon or special meaning unless so expressly stated. Further, this disclosure covers existing and future known equivalents of known components mentioned herein by way of illustration.
[0020] The embodiments described herein provide systems and methods for measuring ocular tissue properties, including ocular thickness, hardness, morphology, and curvature. In some embodiments, an optical coherence tomography (OCT) scanning system is configured to evaluate such ocular tissue properties. Functional extensions of OCT facilitate early disease diagnosis by providing psychological information beyond morphological structure, without the need for contrast agents. For example, one functional extension of OCT is the detection of motion effects, such as blood flow, tissue movement, Brownian motion, and / or dynamic scattering, by utilizing the phase correlation of the components of the OCT signal, which is discussed in further detail below.
[0021] However, some phase decorrelation techniques require a specialized type of OCT system (i.e., PhD OCT) that uses only a single-beam system with a specific scan pattern (MB pattern scan). However, such techniques can be problematic because, during in vivo human testing, the MB scan pattern used by PhD OCT will require several seconds to capture B-scan images. Even with eye-tracking tools, both structural and growth values will be distorted due to the patient's inherent eye movements. Correction for such distortions must be implemented.
[0022] Therefore, some embodiments described herein determine physiological information of ocular tissues by analyzing the intensity and / or phase of OCT signals using an OCT system without further specialization. In some embodiments, tissue property parameters of ocular tissues may be extracted from the intensity or phase of optical signals. In some embodiments, multiple measurements taken at different locations and times may be compared and averaged to provide more accurate results, which is described in further detail below. Advantageously, motion effects can be detected by implementing at least two OCT signals acquired at the same (or substantially the same) location. Such multiple signals can be compared and analyzed to determine motion effects in corneal and / or corneal tissue properties, such as blood flow, tissue movement, Brownian motion, and / or dynamic scattering of light caused by ocular tissue particles, which is discussed in detail below.
[0023] In some embodiments, multiple parallel beams can be used to simultaneously extract ocular tissue characteristics at multiple locations. Simultaneous multi-location measurements ensure faster and more stable measurements with minimal distortion compared to measurements taken at the same location at different times. In some embodiments, a BM scan pattern can be used to provide distortion-free ocular images. In some embodiments, high-resolution ocular images can be generated using multiple B-scan images acquired at the same location, which is discussed in detail below. Implementing the embodiments described herein achieves improved OCT scanning while avoiding the injection of contrast agents and eliminating any requirement to modify conventional OCT systems (e.g., PhD OCT).
[0024] Now for reference Figures 1-2 , Figure 1 An example of an ophthalmic diagnostic system 100 (hereinafter referred to as "System 100") according to some embodiments is illustrated. System 100 can be used for different types of diagnostic and treatment procedures. For example, System 100 can be used to diagnose glaucoma, keratoconus, and / or corneal ectasia. Additionally or alternatively, System 100 can be used to provide data for personalized LASIK or cataract surgery. Figure 1 As shown, system 100 may include control / processing unit 10 and OCT device 15; patient 42 is sitting in chair 9.
[0025] like Figure 2 As shown, in some embodiments, system 100 includes an OCT device 15 that is coupled to and communicates with control / processing unit 10 as shown. OCT device 15 includes controllable components coupled as shown, such as an OCT engine 11, a scanner 13, one or more optical elements / dichroic mirrors 17 and / or focusing lenses 19. Control / processing unit 10 includes a display 12, a processor 14, and a memory 16 coupled as shown. Memory 16 stores computer programs 18 and data.
[0026] In some embodiments, the control / processing unit 10 can control components of the system 100 according to a computer program 18. For example, the control / processing unit 10 controls components (e.g., the OCT engine 11, the scanner 13) to focus the imaging beam of the OCT engine 11 onto a desired location on the eye 22, such as a desired location on the surface of the eye. In some embodiments, the memory 16 can store information used by the control / processing unit 10. For example, the memory 16 can store images of the eye 22, OCT data, and / or other suitable information, and the control / processing unit 10 can retrieve information from the memory 16.
[0027] In various embodiments, computer program 18 includes functions such as controlling the scanning of an imaging beam, which can be guided by a user, such as a medical professional. In some embodiments, control / processing unit 10 can measure ocular tissue characteristics of eye 22, which is discussed in further detail below. Some embodiments include a computer program product comprising a non-transitory computer-readable medium. Some embodiments include a computer program product comprising a non-transitory computer-usable medium containing computer-readable program code. In some embodiments, the computer-readable program code is adapted to be executed by one or more processors to implement the methods described herein.
[0028] Referring specifically to OCT device 15, OCT engine 11 generates and emits optical signal 5. Optical signal 5 can be directed to the tissue of patient 42's eye 22. For example, optical signal 5 can be directed to the ocular surface of eye 22. Scanner 13 laterally directs optical signal 5. Lateral direction refers to a direction orthogonal to the direction of beam propagation. Scanner 13 can be laterally directed in any suitable manner. For example, scanner 13 may include a pair of galvanometer mirrors that can tilt about mutually perpendicular axes. As another example, scanner 13 may include an electro-optic crystal capable of electro-optically manipulating optical signal 5.
[0029] One or more optical elements 17 guide the imaging beam toward the focusing objective 19. The optical elements 17 may act (e.g., transmit, reflect, refract, diffract, collimate, adjust, shape, focus, modulate, and / or otherwise act on) the imaging beam. In some embodiments, the optical elements may include one or more of the following: lenses, prisms, mirrors, diffractive optics (DOE), holographic optics (HOE), and / or spatial light modulators (SLM). In some embodiments, the optical element 17 may include a mirror. In some embodiments, the optical element 17 may include a dichroic mirror. The focusing objective 19 focuses the imaging beam toward a portion of the eye 22 (e.g., the ocular surface of the eye 22). In some embodiments, the focusing objective 19 may include an objective lens (e.g., an f-θ objective).
[0030] OCT engine 11 receives the reflected imaging beam contained in optical signal 5. A portion of the propagating optical signal 5 is reflected off the surface of the eye tissue via backscattering from the eye 22 in the opposite direction to the imaging beam. Backscattering occurs when the beam is deflected, refracted, and / or diffracted through the structures of the eye tissue in the eye 22. In some embodiments, OCT engine 11 may be configured (via display 12) to generate one or more images to provide operable feedback for storage, as described in detail below.
[0031] For example, in various embodiments, the OCT engine 11 is configured to interferometrically analyze the returned imaging beam to provide OCT data representing the position-related structural properties of the eye 22, such as the structural properties of its cornea. For instance, the OCT engine 11 may be configured to provide OCT data representing an image of the cornea / lens / iris / retina at or near the focal location x, y, z, and to provide OCT data representing the position-related optical density n(x, y, z) and the position-related mass density p(x, y, z) of the ocular tissues.
[0032] Although some examples of the OCT device 15 have been described above, in different embodiments, the OCT device 15 may be configured to perform different types of OCT scans, which are described in further detail below. In some embodiments, the OCT device 15 may be configured to perform an M-scan. In other embodiments, the OCT device 15 may be configured to perform a B-scan. In still other embodiments, the OCT device 15 may be configured to perform an MB-scan. In some embodiments, the OCT device 15 may be configured to perform a BM-scan, which is discussed in further detail below. Other types of OCT scans will be apparent to those skilled in the art after a thorough reading of this disclosure.
[0033] Now combine Figures 1-2 refer to Figure 3 , Figure 3 An example of an OCT device 315 is illustrated. Typically, an OCT device 315 may include components relative to... Figures 1-2 The OCT device 15 may include any components and functions described with respect to the OCT device 315. Similarly, the OCT device 15 may include any components and functions described with respect to the OCT device 315. Therefore, for ease of description, similar components of system 100 and OCT device 315 may be referred to interchangeably from time to time. For simplicity, Figure 3 The illustration focuses on example OCT device 315.
[0034] The OCT device 315 includes an OCT engine 311, a scanner 313, an optical element 317, and a focusing objective 319. Typically, the OCT engine 311, scanner 313, optical element 317, and focusing objective 319 are respectively positioned relative to... Figure 2 The OCT engine 11, scanner 13, optical element 17, and / or focusing objective 19 operate as described. Figure 3 In the example, one or more optical elements 317 are shown as dichroic mirrors, and focusing objective 19 is shown as an objective lens.
[0035] With similar Figure 2 In the manner of the OCT engine 11, the OCT engine 311 generates and emits an optical signal 301 that propagates an imaging beam (which is directed to or propagates onto the surface of the ocular tissue 321 of the eye 322), and can subsequently receive a backscattered imaging beam from the eye 322 in the opposite direction to the imaging beam. In some embodiments, the OCT engine 311 emits multiple optical signals, such as three optical signals 301, 303, and 305. In some embodiments, the OCT engine 311 may utilize two optical signals, which is discussed in further detail below.
[0036] like Figure 3 As shown, some embodiments herein advantageously employ multiple parallel beams (e.g., 301, 303, 305) that can be used to simultaneously extract physiological information of ocular tissue 321 at multiple locations. This approach contributes to faster and more stable measurements with minimal distortion compared to multiple measurements at a single location using a single beam, as discussed in further detail below.
[0037] Now combine Figures 1-3 refer to Figures 4A-4C , Figure 4A A graph 400A is plotted, which depicts the relationship between the time and signal difference of the components of the optical signal (e.g., 301, 303, 305) emitted by the OCT engine 311. The optical signal components include complex signal 401, phase signal 403, or amplitude signal 405.
[0038] As discussed in further detail below, in some embodiments, motion signals within the ocular tissue 321 can be obtained using the difference between amplitude (intensity), phase, or complex signals (e.g., t2Δ2 – t1Δ1). To quantify motions within the ocular tissue 321 that are difficult to detect, some embodiments implement phase decorrelation OCT to measure the growth constant of the change in time-correlation complex value. The growth constant value can be used to quantify the characteristics of the ocular tissue 321, which is discussed further below.
[0039] For clarity, in an OCT system (e.g., 100), the detected signal is typically interference fringes. A depth-resolved OCT signal is provided by performing a Fourier transform on the interference fringes to convert the signal from the optical domain (wavelength or time) to the depth domain. Depth-resolved OCT signals are represented as complex values containing both amplitude (intensity) and phase information. A complex-valued signal can be represented as: E = I e (-iΦ) Equation (1) In Equation 1, E is a complex signal, I is the amplitude of the signal (where the intensity is the square of I), Φ is the phase of the signal, and i is the imaginary unit (i = π / 2). 2 = -1). Exponential term e (-iΦ) It is a compact way of representing phase information, combining both the real and imaginary components of a complex signal in a single expression.
[0040] The complex-valued signal (E) is the result of an interference pattern (i.e., fringes) produced when the reference beam (i.e., the propagating portion of optical signal 5) and the sample beam (i.e., the reflected portion of optical signal 5) are recombined in an OCT system (e.g., 100). The amplitude (I) represents the intensity of the reflected light, while the phase (Φ) carries information about the difference in relative path length between the reference beam and the sample beam.
[0041] Therefore, the amplitude and phase information contained in complex signals can be used to generate high-resolution cross-sectional images of tissues and can advantageously provide insights into the optical and biomechanical properties of ocular tissues, such as stiffness, which will be discussed further below.
[0042] like Figure 4A As shown, in the OCT device 315, the signal difference between multiple acquired OCT signals sequentially reflected from the same location can increase as the time difference between the acquired signals increases. The increase in signal difference over time can be used to quantify the intensity of motion (e.g., flow or Brownian motion) corresponding to the ocular tissue 321. The relationship between the signal differences between acquired OCT signals at the same location acquired at different times can be fitted using an exponential growth function. For example, as... Figure 4B As shown, the solid circle plots the measured signal difference 407, while the dashed line represents the exemplary curve 409 fitted by the exponential growth function.
[0043] This will be discussed in detail below. Figure 4B In this study, the growth constant of the phase decorrelation-time relationship is directly related to the Brownian diffusion coefficient and can be used to quantify ocular tissue properties. For example, by comparing the measured Brownian diffusion coefficient with clinical test data. For clarity, a brief review follows:
[0044] In OCT, phase decorrelation signal processing can be used to measure the motion of scattered photons in tissue, typically caused by “scatterers” within the ocular tissue 321. This will be discussed in detail below; “scatterers” generally refer to particles or interfaces within the ocular tissue 321 that cause light scattering.
[0045] The following discussion further explores how, when OCT signals (e.g., 5, 301, 303, 305) are incident on ocular tissue 321, light from such OCT signals penetrates the ocular tissue 321 to a depth depending on the properties of the ocular tissue 321. As the light from the OCT signals travels through the ocular tissue 321, it encounters various ocular structures, such as cells, organelles, collagen fibers, ocular layers, and other known microstructures. Each of these structures possesses different optical properties, such as refractive index. When light from the OCT signals encounters such structures, some light is reflected back, and some is scattered (i.e., the light is deflected in different directions instead of passing through directly). Such structures within the ocular tissue 321 that cause light scattering are referred to herein as "scatterers."
[0046] Analysis of light scattering can be advantageous because such scattered light can be collected and measured by the OCT device 315 to form an image. For example, as discussed in further detail below, by measuring the time delay and intensity of the returned light in optical signals 301, 303, and 305, the OCT device 315 is able to construct a depth-resolved image of the ocular tissue 321. The distribution, size, and nature of the scatterers within the ocular tissue 321 contribute to the specific features and contrasts that can be seen in the OCT image generated by the OCT device 315. Such OCT images (i.e., OCT data) can be displayed to facilitate the non-invasive visualization of the movement of internal microstructures within the ocular tissue 321 over time.
[0047] The following section discusses in further detail how the Brownian motion, or apparent Brownian motion, of particles within the ocular tissue 321 can be determined by visualizing the movement of the internal microstructures or particles. Brownian motion refers to the random motion of particles suspended in the ocular tissue 321, caused by collisions between such particles and other randomly moving molecules and / or particles within the ocular tissue 321.
[0048] As used herein, “apparent Brownian motion” refers to the motion of particles in ocular tissue 321 observed by OCT device 15, which appears random and diffuse, similar to real Brownian motion. However, such motion can be influenced by other factors, including heat, light, and ambient electromagnetic fields. For example, the motion of scatterers within ocular tissue measured by OCT device 315 may be affected by fluid flow within the ocular tissue, the patient’s cardiac or respiratory movements, and / or instrument noise and ambient noise or artifacts. Such factors can contribute to the apparent random motion observed in ocular tissue particles via OCT device 315.
[0049] As used herein, “apparent Brownian motion” means that the motion can appear to be Brownian motion, and may also include non-Brownian motion influenced by other factors. Furthermore, as used herein, the term “apparent diffusion coefficient” quantifies a measure of such apparent random / Brownian motion, which can be analyzed to determine ocular tissue properties, microstructure, and physiology as discussed herein.
[0050] Therefore, as discussed above, OCT signals 301, 303, and 305 are affected by Brownian motion of scatterers within ocular tissue 321. This motion of scatterers causes changes in the phase and amplitude of OCT signals 301, 303, and 305 over time. By comparing such phase or amplitude changes in OCT signals from successive OCT scans (e.g., line A, further discussed below) over time, the embodiments described herein determine such phase or amplitude changes between successive scans (i.e., phase / amplitude decorrelation). Such phase / amplitude decorrelation is advantageous for measuring or quantifying the degree of phase change from one scan to subsequent scans, which is discussed in further detail below.
[0051] In some embodiments, system 100 can model and display the relationship between phase decorrelation and time in OCT signals 301, 303, and 305, wherein such modeling can be characterized by a growth function. This growth function can advantageously be represented by a growth constant that captures the rate of change of phase decorrelation over time.
[0052] Therefore, the embodiments described herein provide a way to correlate the rate of change captured by phase decorrelation with the Brownian motion of the scatterer within the ocular tissue 321. Because, as discussed above, the Brownian motion within the ocular tissue 321 causes phase decorrelation over time, the rate of increase of the phase decorrelation (i.e., the growth constant) can be directly correlated with the Brownian diffusion coefficient, which quantifies the random motion of the scatterer. The more motion, the faster the phase decorrelation increases, and therefore the higher the Brownian diffusion coefficient.
[0053] Therefore, by measuring the growth constant of the phase decorrelation versus time relationship in OCT signals 301, 303, and 305, the embodiments described herein determine the Brownian diffusion coefficient of the ocular tissue 321. Moreover, such a diffusion coefficient can be used to quantify the characteristics of the ocular tissue 321, such as its stiffness. For example, in the cornea, because the scatterer is embedded within the ocular tissue 321, the motion of such the scatterer is influenced by the properties (including stiffness) of the surrounding ocular tissue. Therefore, by determining the diffusion coefficient, the system 100 can deduce the stiffness of the ocular tissue 321. The above embodiments can be similarly applied to the amplitude of OCT signals or a combination of amplitude and phase signals.
[0054] Therefore, the embodiments described herein provide direct measurements that can be correlated with ocular biomechanics and used for the diagnosis, prevention, and treatment of ocular diseases, as described in further detail below. For example, techniques involving assessing water level or volume within ocular tissues and the degree of collagen restriction are used to determine ocular biomechanics and diffusion coefficients.
[0055] Figure 4C An example of operation 400C for measuring ocular tissue characteristics is illustrated. In some embodiments, operation 400C may be implemented by a system capable of processing OCT data (e.g., system 100). Although any number of systems may implement operation 400C in whole or in part, for the sake of simplicity, it will be discussed in relation to... Figures 1-3 The system 100 is used as an example component to describe operation 400C.
[0056] Therefore, based on the relationship between signal differences in the acquired OCT signals discussed above, the embodiments described herein implement operation 400C for determining ocular tissue characteristics. Operation 400B may begin with operation 402c: determining amplitude or phase changes associated with multiple scans based on phase and amplitude information of the complex OCT signal. The amplitude or phase change characterizes the change of the complex OCT signal over time. Operation 402c may be performed by the OCT device 315.
[0057] In operation 404c, the OCT device 315 can determine the growth constant based on amplitude or phase change parameters. In operation 406c, the OCT device 315 can determine the apparent diffusion coefficient of particles associated with ocular tissue based on the growth constant. In operation 408c, the OCT device 315 can determine quantitative parameters of ocular tissue based on the apparent diffusion coefficient or growth constant. These quantitative parameters can be compared with clinical data to determine the condition or disease of the patient's eye.
[0058] Now for reference Figure 4D , Figure 4DOperation 400D (e.g., 301, 303, 305) is described for determining amplitude or phase changes associated with the amplitude, phase, and / or complex signals emitted from OCT engine 311. Figure 4C Operation 402c). The amplitude, phase, and / or complex components (e.g., 401, 403, 405) of optical signals 301, 303, and 305 can be used to determine eye characteristics according to Operation 400C discussed above. In Operation 400D, when determining the signal difference, absolute difference, decorrelation, variance, or other methods can be used.
[0059] As implemented herein, the dataset may include at least three curves (e.g., phase signal 403) obtained by the OCT engine 311. Such curves can be used to determine the corresponding growth value for each curve. For example, the average of at least three growth values can be used to obtain a more accurate or optimized growth value. Figure 4D As shown, a total of n measurements can be performed at the same location. In some embodiments, the n measurements can be performed sequentially or non-sequentially using BM mode scanning or MB mode scanning, which is discussed in further detail below.
[0060] like Figure 4D As shown, the "stripes" acquired from the measurement are calibrated and allocation compensation is performed. In the context of optical coherence tomography (OCT), the term "stripes" refers to the interference pattern produced when the reference beam and the sample beam are recombined after being split by a beam splitter in system 100. Such interference patterns / stripes contain depth information about the ocular tissue 321.
[0061] For clarity, in OCT, a low-coherence light source is used to generate two beams that are split into two: a reference beam and a sample beam. The sample beam is directed toward the tissue being imaged, while the reference beam is directed toward a reference mirror or reflective surface. Both beams are reflected back to the beam splitter and recombined. This recombining of the reference and sample beams produces an interference pattern, or fringes, which depends on the path length difference between the reference and sample beams. The fringe pattern carries information about the depth and reflectivity of the tissue layer because light reflected from different depths within the tissue will have different path length differences relative to the reference beam.
[0062] In some embodiments, system 100 detects fringe patterns, which are analyzed to extract depth information. This depth information can be used to generate high-resolution cross-sectional images of ocular tissue 321. As discussed above, performing a Fourier transform on the detected fringe signal and converting it from the optical domain (wavelength or time) to the depth domain provides a depth-resolved OCT signal. The OCT signal (e.g., 301, 303, 305) is a complex number, and the increments can be derived from these complex numbers using known techniques.
[0063] Therefore, in some embodiments, operation 400D includes performing a first OCT measurement using the position of system 100 within the eye. In operation 402d, system 100 determines a first fringe based on the first OCT measurement, and calibrates the first fringe in operation 404d. Next, in operation 406d, OCT device 315 may perform dispersion compensation on the first fringe. In system 100, dispersion compensation corrects for dispersion mismatch between the sample signal and the reference signal. Such dispersion mismatch may be caused by different optical paths taken by the light in the sample arm and reference arm of the interferometer of OCT engine 311. Performing dispersion compensation may include adjusting the optical path length or dispersion properties of the reference signal to match the optical path length or dispersion properties of the sample signal. By applying dispersion compensation, system 100 can maintain high resolution and contrast in the generated image, thereby enhancing the accuracy of observations and measurements derived from such images.
[0064] In operation 408d, OCT device 315 performs a first Fast Fourier Transform (FFT) on the calibrated and compensated first fringe, the output of which can correspond to the dataset, as described above. In operation 410d, OCT device 315 can determine a first depth-coded OCT signal based on the first output of the FFT, wherein the first depth-coded OCT signal corresponds to a first set of complex numbers. In operation 412d, system 100 can determine the amplitude and phase of the first depth-coded OCT signal based on the first set of complex numbers, as discussed above.
[0065] In operation 414d, operations 402d to 412d are repeated for n measurements. For example, in some embodiments, system 100 can perform a second OCT measurement at this location within the eye. System 100 then determines a second fringe based on the second OCT measurement and can calibrate the second fringe. Next, system 100 performs dispersion compensation on the second fringe and performs a second FFT on the calibrated and compensated second fringe. System 100 can then determine a second depth-encoded OCT signal based on the second output of the FFT, wherein the second depth-encoded OCT signal corresponds to a second set of complex numbers. System 100 then determines the amplitude and phase of the second depth-encoded OCT signal based on the second set of complex numbers.
[0066] In operation 416d, system 100 determines the signal difference between the first OCT measurement and the second OCT measurement based on a comparison of the amplitude and / or phase shift of the first depth-encoded OCT signal with the amplitude or phase shift of the second depth-encoded OCT signal. In some embodiments, the first and second OCT measurements are performed simultaneously at different locations on the cornea. For example, the middle, top, and / or bottom portions of ocular tissue 321. In some embodiments, the different locations may be locations spaced at least 0.1 mm apart from each other.
[0067] To determine the growth function, system 100 can plot a curve relating the signal difference to the time difference between the acquired OCT signals (e.g., 401, 403, 405). System 100 can fit the plotted curve with an exponential growth function to obtain at least three growth values. A weighted average of these at least three growth values is then taken to obtain an optimized growth value, as described above.
[0068] Similar to or the same as discussed above, system 100 determines ocular tissue characteristics based on optimized growth values, wherein the optimized growth values of phase decorrelation and time relationship are directly related to the Brownian diffusion coefficient. In some embodiments, determining the signal difference may include utilizing one or more of the following: absolute difference, decorrelation, and / or variance calculation. Some of the above embodiments may be further implemented using: Doppler OCT, Doppler variance OCT, intensity-based Doppler, speckle variance, phase variance, optical microangiography, amplitude decorrelation, phase decorrelation, and / or dynamic scattering. In various embodiments, the obtained ocular tissue characteristics may be stored in memory 16 or other storage devices with respect to the patient. Additionally or alternatively, the obtained ocular tissue characteristics may be displayed to the user or operator of system 100.
[0069] Now combine Figures 1-4C refer to Figures 5A-5B , Figure 5A A graph 500A was plotted, which depicts the relationship between the imaging position and time during MB mode scanning by the laser beam. Figure 5B Graph 500B is plotted, which shows the relationship between imaging position and time during BM mode scanning by the laser beam. A brief overview follows:
[0070] OCT systems offer various scanning modes to obtain different types of images or datasets, depending on clinical requirements and the eye structures being examined. An A-scan is a one-dimensional depth profile of a sample or tissue. By measuring the interference pattern produced by reflected light, system 100 can obtain information about the depth and reflectivity of tissue layers, thus generating a depth profile. An A-scan can be performed to measure the axial length of the eye 322 and assess the anterior chamber depth and lens thickness. Such information is helpful for diagnosing and monitoring the condition of the eye 322. An M-scan is multiple A-scans taken at the same location.
[0071] B-scans involve acquiring a single cross-sectional image of a tissue by performing multiple A-scans (i.e., linear scans along a specified axis). A B-scan is a scanning mode that provides a two-dimensional view of the tissue's internal structure. In some embodiments, the system 100 may acquire multiple B-scans at adjacent locations to generate a three-dimensional dataset of ocular tissue 321; this is referred to as a volumetric scan or C-scan. The volumetric scan mode provides a comprehensive view of the tissue structure and can be used to visualize the entire macular region or analyze the optic nerve.
[0072] like Figure 5A As shown, MB mode scanning is a term that combines M mode (multiple A scans at the same location) and B mode (scans at different locations). In ophthalmology, MB mode scanning can be performed in the evaluation of the eye 322 and the orbit.
[0073] MB mode scanning combines M-mode and B-mode technologies to provide a comprehensive assessment of both static and dynamic aspects of the eye. M-scans help extract exponential growth curves at each location. B-scans allow for the formation of cross-sectional images.
[0074] As shown in the stepped progression of graph 500A, the MB mode scan first pauses at the same location for a period of time, then moves to the next location and pauses for the same amount of time. In MB scan mode, an M-scan at the same location allows for the acquisition of curves relating amplitude / phase / complex signal difference to time, and provides information on the tissue biomechanics at that specific location. By changing locations using B-scans, the biomechanics at different locations can be determined. In some embodiments, in addition to the MB scan mode discussed above, which pauses at the same location to acquire multiple A-lines and then moves to another location, a BM scan mode can be utilized.
[0075] In some embodiments, when rapid OCT processing is advantageous, the BM scanning mode is advantageously implemented as follows: In some embodiments, the BM mode shown in graph 500B can be used simultaneously or in combination to provide a comprehensive assessment of both static and dynamic aspects of ocular tissue 321. The number of A-lines in each B-scan of the BM scanning mode will depend on the A-line speed. BM scanning is preferred when a single B-scan can be completed in less than 1 millisecond.
[0076] In some embodiments, the first B-scan image in a BM scan can be used as a baseline image to register subsequent B-scan images. The registered B-scan images form a dataset for further processing. In some embodiments, such registered images / datasets can be averaged to obtain speckle-free, high-resolution images. The averaged dataset can be used to obtain growth values or other parameters for evaluating ocular characteristics.
[0077] Therefore, the above embodiments can provide a diagnostic device with submicron resolution capable of measuring the biomechanical properties of diseased or healthy ocular tissue. One or more of the above embodiments can be implemented to design personalized treatment programs for cataract and LASIK surgery, thereby improving the predictability of astigmatism treatment during cataract surgery, identifying patients at risk of post-LASIK complications, and / or improving the predictability of ocular treatment. Utilizing the above embodiments to determine such information can help include new metrics in treatment planning algorithms, thereby improving the predictability of corneal treatment and surgeon confidence. The ability to measure biomechanical properties and use such results in treatment algorithms allows for more accurate support of: cataract outcomes from patient-specific SIA, LRI results from patient-specific calculations, treatment decisions based on corneal refractive index (Px), and Ortho-k results.
[0078] The subject matter disclosed above should be considered illustrative rather than restrictive, and the appended claims are intended to cover all such modifications, enhancements, and other embodiments falling within the true spirit and scope of this disclosure. Therefore, for the maximum permissible extent permitted by law, the scope of this disclosure shall be determined by the broadest possible interpretation of the appended claims and their equivalents, and should not be limited to or restricted by the foregoing detailed description.
Claims
1. An optical coherence tomography (OCT) scanning system for measuring the properties of ocular tissues of the cornea in a patient's eye, the system comprising: An OCT scanner is configured to perform a scanning sequence on ocular tissue via optical signals, the scanning sequence comprising performing multiple scans on the ocular tissue to obtain OCT data based on a reflective version of the optical signals, the OCT data representing phase data of the reflective version of the optical signals; as well as The computer includes a processor configured to: Control signals are provided to the OCT scanner to implement the scanning sequence; Determine the rate of change of the phase data associated with the multiple scans, the rate of change of the phase data characterizing the change of the reflected version of the optical signal over time; The growth constant of the reflected version of the optical signal is determined based on the rate of change of the phase data; The diffusion coefficient associated with the cornea is determined based on the growth constant; as well as The quantitative parameters of the cornea are determined based on the diffusion coefficient associated with the cornea.
2. The system as claimed in claim 1, wherein, The OCT data represents the amplitude change of the reflected version of the optical signal.
3. The system as described in claim 1, wherein, The scanning sequence includes BM mode scanning, wherein the OCT scanner is configured to: Execute multiple B-scan OCT images corresponding to two-dimensional cross-sectional images of the ocular tissue; Execute multiple M-mode OCT images; and Determine the average value of the plurality of B-scan OCT images.
4. The system as described in claim 3, wherein, Performing multiple scans on the eye tissue includes: A first scan corresponding to a first time is performed at a location in the cornea; A second scan corresponding to a second time is performed at the location in the cornea; The difference between the first measurement and the second measurement is determined based on the OCT data from the first scan or the second scan; Perform one or more subsequent scans at the location corresponding to one or more subsequent times; and The optical signal is determined based on the difference between the first measurement and the second measurement, and the average of one or more differences between the first measurement and one or more subsequent measurements.
5. The system as described in claim 4, wherein, Determining the difference between the first measurement and the second measurement includes comparing the amplitude or phase of the first measurement with the amplitude or phase of the second measurement.
6. The system of claim 1, wherein, The rate of change of the phase data is determined to correspond to the multiple scans.
7. The system as claimed in claim 1, wherein, The multiple scans performed include either BM scan mode or MB scan mode.
8. The system as claimed in claim 1, wherein, The multiple scans refer to performing at least two scans simultaneously at at least two different locations on the cornea.
9. The system of claim 8, wherein, The multiple scans refer to performing three scans simultaneously at at least three different locations on the cornea.
10. A method for real-time measurement of corneal tissue characteristics at multiple ocular locations, the method comprising: At the optical coherence tomography (OCT) device: Multiple scans are performed on the ocular tissue of the cornea to obtain OCT data representing OCT signals, the OCT signals including phase data and amplitude data; At the computer connected to the OCT device: Determine the rate of change of the amplitude data or the phase data associated with the multiple scans, the rate of change of the phase data or the amplitude data characterizing the change of the reflected version of the optical signal over time; The growth constant of the reflected version of the optical signal is determined based on the rate of change of the amplitude data or the phase data; The diffusion coefficient associated with the ocular tissue is determined based on the growth constant; as well as Quantitative parameters of the ocular tissue are determined based on the diffusion coefficient associated with the ocular tissue.
11. The method of claim 10, wherein, The multiple scans include BM mode scans, and wherein the OCT device is further configured to: Execute multiple B-scan OCT images corresponding to a two-dimensional cross-sectional image of the cornea; Execute multiple M-mode OCT images; and Determine the average value of the plurality of B-scan OCT images.
12. The method of claim 10, wherein, Performing multiple scans on the cornea includes: A first scan corresponding to a first time is performed at a location in the cornea; A second scan corresponding to a second time is performed at the location in the cornea; Determine the difference between the first measurement and the second measurement in the first scan or the second scan; Perform one or more subsequent scans at the location corresponding to one or more subsequent times; and The OCT signal is determined based on the difference between the first measurement and the second measurement, and the average of one or more differences between the first measurement and one or more subsequent measurements.
13. The method of claim 12, wherein, Determining the difference between the first measurement and the second measurement includes comparing the amplitude or phase of the first measurement with the amplitude or phase of the second measurement.
14. The method of claim 10, wherein, The multiple scans performed include MB scan mode.
15. The method of claim 10, wherein, The multiple scans performed include the BM scan mode.
16. The method of claim 10, wherein, Performing the multiple scans includes performing at least two scans simultaneously at at least two different locations on the cornea.
17. The method of claim 10, wherein, The multiple scans refer to performing three scans simultaneously at at least three different locations on the cornea.
18. A computer program product comprising a non-transitory computer-usable medium containing computer-readable program code adapted to be executed by one or more processors to implement a method comprising: OCT data representing optical signals, including phase and amplitude information, is received from an optical coherence tomography (OCT) device and generated by performing multiple scans on the cornea. Determine the rate of change of amplitude or phase data associated with the multiple scans, the rate of change of phase or amplitude data characterizing the change of the reflected version of the optical signal over time; The growth constant of the reflected version of the optical signal is determined based on the rate of change of the amplitude data or the phase data; The diffusion coefficient associated with the cornea is determined based on the growth constant; as well as The quantitative parameters of the cornea are determined based on the diffusion coefficient associated with the cornea.
19. The computer program product of claim 18, wherein: Performing multiple scans on the cornea includes: A first scan corresponding to a first time interval is performed at a location in the cornea, and A second scan corresponding to a second time period is performed at the location in the cornea; and The method further includes: The difference between the first measurement and the second measurement is determined based on the OCT data from the first scan or the second scan; Provide control signals to the OCT device to perform one or more subsequent scans corresponding to one or more subsequent times at the location; and The OCT signal is determined based on the difference between the first measurement and the second measurement, and the average of one or more differences between the first measurement and one or more subsequent measurements.
20. The computer program product of claim 19, wherein, Determining the difference between the first measurement and the second measurement includes comparing the amplitude or phase of the first measurement with the amplitude or phase of the second measurement.
